J. Finlayson

发表

Differential gene expression analysis in early and late erythroid progenitor cells in β‐thalassaemia

John K. McCooke, M. Bellgard, R. Ghassemifar, 2015, British journal of haematology.

α-Thalassemia Trait Caused by Frameshift Mutations in Exon 2 of the α2-Globin Gene: HBA2:c.131delT and HBA2:c.143delA

J. Beilby, R. Ghassemifar, J. Finlayson, 2012, Hemoglobin.

Hb Lynwood [α107(G14) (–T) (α2) HBA2:c.323delT)] in Conjunction with the α3.7 Deletion Produces a Moderately Severe α-Thalassemia Phenotype

J. Beilby, R. Ghassemifar, J. Finlayson, 2011, Hemoglobin.

A molecular tool to assess the pathological relevance of alpha-globin DNA variants

J. Beilby, R. Ghassemifar, J. Finlayson, 2012, Pathology.

Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes.

J. Finlayson, N. Novitzky, C. D. du Toit, 2000, Experimental hematology.

The Effect of Nonsense Mediated Decay on Transcriptional Activity Within the Novel β-Thalassemia Mutation HBB: c.129delT

R. Ghassemifar, Luke Forster, J. Finlayson, 2015, Hemoglobin.

Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort

W. Langdon, C. Thien, R. Ghassemifar, 2011, Pathology.

Experimental Characterization of Hb Flurlingen (HBA2: c.177 C > G, p.His > Gln) and Hb Boghé (HBA2: c.177 C > A, p.His > Gln) Reveals Contradictory HBA2 Expression and Translation Patterns Despite Identical Amino Acid Substitutions

R. Ghassemifar, J. Finlayson, Talal Qadah, 2015, Hemoglobin.

Identification and Characterization of Two Novel and Differentially Expressed Isoforms of Human α2- and α1-Globin Genes

R. Ghassemifar, Luke Forster, J. Finlayson, 2012, Hemoglobin.

Molecular and cellular analysis of three novel alpha2-globin gene promoter mutations [HBA2: c.-59C>T], [HBA2 c.-81C>A] and [HBA2 c.-91G>A] reveal varying patterns of transcriptional and translational activities

R. Ghassemifar, J. Finlayson, Talal Qadah, 2014, Pathology.

Thalassemia in Western Australia: 11 novel deletions characterized by Multiplex Ligation-dependent Probe Amplification.

P. Giordano, C. Harteveld, M. Phylipsen, 2010, Blood cells, molecules & diseases.

Differential expression of the Bcl-2 and Bax isoforms in CD19 positive B-lymphocytes isolated from patients diagnosed with chronic lymphocytic leukaemia

R. Ghassemifar, D. Joske, Luke Forster, 2012, Pathology.

Molecular Characterization of Hb Hamilton Hill (HBA2: c.388delC), a Novel HBA2 Variant Generating a Premature Termination Codon and Truncated HBA2 Chain

R. Ghassemifar, J. Finlayson, Talal Qadah, 2015, Hemoglobin.

Molecular and Cellular Characterization of a New α-Thalassemia Mutation (HBA2:c.94A>C) Generating an Alternative Splice Site and a Premature Stop Codon

J. Beilby, R. Ghassemifar, J. Finlayson, 2012, Hemoglobin.

Cell cycle, proliferation and apoptosis in erythroblasts cultured from patients with β‐thalassaemia major

S. Cornwall, R. Ghassemifar, Luke Forster, 2016, British journal of haematology.

BRAF mutation detection in hairy cell leukaemia from archival haematolymphoid specimens

W. Erber, B. Amanuel, D. Spagnolo, 2015, Pathology.

Two New α1-Globin Gene Point Mutations: Hb Nedlands (HBA1:c.86C>T) [α28(B9)Ala→Val] and Hb Queens Park (HBA1:c.98T>A) [α32(B13)Met→Lys]

P. Giordano, C. Harteveld, M. Phylipsen, 2010, Hemoglobin.

Alpha thalassaemia due to non-deletional mutations on the -3.7 alpha globin fusion gene: laboratory diagnosis and clinical importance

R. Ghassemifar, J. Finlayson, Annie Chow, 2013, Pathology.

RNF187 is Downregulated Following NF-κB Inhibition in Late Erythroblasts

R. Ghassemifar, Luke Forster, J. Finlayson, 2016, Biochemical Genetics.

Molecular and Cellular Analysis of a Novel HBA2 Mutation (HBA2: c.94A>G) Shows Activation of a Cryptic Splice Site and Generation of a Premature Termination Codon

P. Joly, R. Ghassemifar, J. Finlayson, 2014, Hemoglobin.